Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach

Haemophilia. 2006 Jul;12(4):429-34. doi: 10.1111/j.1365-2516.2006.01288.x.
No abstract available

Publication types

  • Congress

MeSH terms

  • Blood Coagulation Factor Inhibitors / blood*
  • Coagulants / administration & dosage
  • Coagulants / antagonists & inhibitors
  • Coagulants / immunology
  • Drug Administration Schedule
  • Evidence-Based Medicine
  • Factor VIII / administration & dosage
  • Factor VIII / antagonists & inhibitors*
  • Factor VIII / immunology
  • Hemophilia A / immunology*
  • Humans
  • Immune Tolerance*
  • Isoantibodies / blood
  • Male
  • Risk Factors

Substances

  • Blood Coagulation Factor Inhibitors
  • Coagulants
  • Isoantibodies
  • Factor VIII